Drug · DIN 02558467
LONGAVO
PREFILLED SYRINGE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 18, 2025.
- Drug Identification Number (DIN)
- 02558467
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Suspension (Extended-Release)
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 100 MG | 0.28 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 18, 2025: NOC 35530New Drug Submission (NDS)
Other DINs named LONGAVO
- DIN 02558440 · Approved
- DIN 02558459 · Approved
- DIN 02558475 · Approved